Comparative cardiovascular effects of GLP‐1 agonists using real‐world data

Endocrinology, diabetes & metabolism, 2023-05, Vol.6 (3), p.e339-n/a [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Ltd. ;2023 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd. ;2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2398-9238 ;EISSN: 2398-9238 ;DOI: 10.1002/edm2.339 ;PMID: 36825925

Full text available